Mode d’infection par le parasite (0:16min), mauvaise et bonne immunité (0:36): 

Passage du parasite dans le cerveau (0:26min) 

• Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, Tardieux I. CD11c- and CD11b expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain.  Blood. 2006;107(1):309-16 

Etudes comportementales sur les souris infectées (0:53min): 

• Ingram WM, Goodrich LM, Robey EA, Eisen MB. Mice infected with low-virulence strains of  Toxoplasma gondii lose their innate aversion to cat urine, even after extensive parasite  clearance. PloS one. 2013;8(9):e75246. 
• Vyas A, Kim SK, Giacomini N, Boothroyd JC, Sapolsky RM. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proceedings of  the National Academy of Sciences of the United States of America. 2007;104(15):6442-7 

Les maladies neurologiques et les maladies mentales (1:19min): 

• Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z. Increased risk of traffic accidents in subjects  with latent toxoplasmosis: a retrospective case-control study. BMC infectious diseases.  2002;2:11. 
• Daher D, Shaghlil A, Sobh E, Hamie M, Hassan ME, Moumneh MB, et al. Comprehensive  Overview of Toxoplasma gondii-Induced and Associated Diseases. Pathogens. 2021;10(11). • Yang HY, Chien WC, Chung CH, Su RY, Lai CY, Yang CC, et al. Risk of dementia in patients with  toxoplasmosis: a nationwide, population-based cohort study in Taiwan. Parasites & vectors.  2021;14(1):435. 
• Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with  schizophrenia: a meta-analysis. Schizophrenia bulletin. 2007;33(3):729-36. 

Les traitements contre le parasite (1:41min): 

• CDC – Toxoplasmosis – Resources for Health Professionals
• Shammaa AM, Powell TG, Benmerzouga I. Adverse outcomes associated with the treatment  of Toxoplasma infections. Scientific reports. 2021;11(1):1035.